This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Number of new drugs launched in the U.S. 2003-2015
Number of new molecular entities launched in the U.S. from 2003 to 2015
This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Loading statistic...
| New Mechanism | Orphan | Existing Mechanism | |
|---|---|---|---|
| 2003 | 13 | 6 | 5 |
| 2004 | 12 | 5 | 3 |
| 2005 | 11 | 4 | 6 |
| 2006 | 10 | 9 | 9 |
| 2007 | 6 | 5 | 7 |
| 2008 | 7 | 6 | 7 |
| 2009 | 8 | 7 | 18 |
| 2010 | 9 | 8 | 9 |
| 2011 | 11 | 12 | 10 |
| 2012 | 12 | 8 | 8 |
| 2013 | 8 | 17 | 11 |
| 2014 | 7 | 20 | 18 |
| 2015 | 14 | 15 | 14 |
| New Mechanism | Orphan | Existing Mechanism | |
|---|---|---|---|
| 2003 | 13 | 6 | 5 |
| 2004 | 12 | 5 | 3 |
| 2005 | 11 | 4 | 6 |
| 2006 | 10 | 9 | 9 |
| 2007 | 6 | 5 | 7 |
| 2008 | 7 | 6 | 7 |
| 2009 | 8 | 7 | 18 |
| 2010 | 9 | 8 | 9 |
| 2011 | 11 | 12 | 10 |
| 2012 | 12 | 8 | 8 |
| 2013 | 8 | 17 | 11 |
| 2014 | 7 | 20 | 18 |
| 2015 | 14 | 15 | 14 |
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Show more- Show sources information
- Show publisher information
- Release date
- April 2016
- Region
- United States
- Survey time period
- 2003 to 2015
- Supplementary notes
-
New Molecular Entity (NME): A novel molecular or biologic
entity or combination where at least one element is novel.
This statistic was assembled from several IMS Health reports.
NME launches in the U.S. by year of launch, regardless of timing of FDA approval.
New mechanism: First product with a new mechanism of action for its FDA approved indication.
Orphan: Drugs with one or more orphan indications approved by FDA at launch.
Existing mechanism: Subsequent products with an existing mechanism of action for an indication. - Open this statistic in...
More information
- Region
- United States
- Survey time period
- 2003 to 2015
- Supplementary notes
-
New Molecular Entity (NME): A novel molecular or biologic
entity or combination where at least one element is novel.
This statistic was assembled from several IMS Health reports.
NME launches in the U.S. by year of launch, regardless of timing of FDA approval.
New mechanism: First product with a new mechanism of action for its FDA approved indication.
Orphan: Drugs with one or more orphan indications approved by FDA at launch.
Existing mechanism: Subsequent products with an existing mechanism of action for an indication. - Open this statistic in...
Other interesting statistics
+
+Top pharmaceutical companies located in Canada by revenue 2016
+
+World pharmaceutical sales 2015-2017 by region
+
+Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
+
+Pfizer's total revenue 2006-2017
+
+Johnson & Johnson's total revenue 2005-2017
+
+2018 list of top U.S. biotech and pharmaceutical companies based on revenue
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax
(New York residents only).
Prices do not include sales tax
(New York residents only).
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Clinical trials
- 92 page/s
- English
- pptx
- Detailed references
Everything On "Clinical trials" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "U.S. pharmaceutical industry"
- Contribution to global pharma
The most important statistics
- Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*World pharmaceutical market distribution by submarket 2014-2017
- Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*World pharmaceutical sales 2015-2017 by region
- Market share of top 10 national pharmaceutical markets worldwide in 2016*Market share of the leading 10 global pharmaceutical markets 2016
- Growth of top 10 national pharmaceutical markets worldwide from 2011 to 2016*Top 10 global pharmaceutical markets: growth 2011-2016
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- Leading countries in global life sciences mergers and acquisitions in 1st half of 2018Leading countries in life sciences sector M&As HY1 2018
- Overview
The most important statistics
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*U.S. total medicine spending 2002-2016
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2016
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*U.S. top 20 prescribed drugs based on sales 2016
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)Top U.S. pharma products by prescriptions 2016
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)Pharmaceutical channel distribution by U.S. spending 2014-2016
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*Pharmaceutical preparation manufacturing gross output 1998-2016
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Companies
The most important statistics
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*2018 list of top U.S. biotech and pharmaceutical companies based on revenue
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*Pharmaceutical corporations by U.S. revenue 2016
- Johnson & Johnson's total revenue from 2005 to 2017 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2017
- Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)Pfizer's total revenue 2006-2017
- Total revenue of Merck & Co. from 2006 to 2017 (in million U.S. dollars)Merck & Co - total revenue 2006-2017
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)Ad spending of pharmaceutical companies in the U.S. 2015
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*Highest pharmaceutical company penalties in the U.S. 2012-2015
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)Top pharmaceutical companies located in Canada by revenue 2016
- Research and development
The most important statistics
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2017
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017U.S. pharma industry R&D spending as a percent of total revenues 1990-2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*Pharmaceuticals: biopharma medicines in development 2018 by category
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
- Number of new molecular entities launched in the U.S. from 2003 to 2015Number of new drugs launched in the U.S. 2003-2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014Number of FDA approved orphan designations in the U.S. 2000-2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)U.S. sales growth of new brand medicines 2011-2015
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014R&D expenditure per employee in U.S. sectors 2000-2014
- Generics
The most important statistics
- Top 20 companies based on unbranded generics U.S. market share during 2014-2015*Market share of unbranded generics by top 20 companies in U.S. 2014-2015
- Change in branded and generic medication spending in the United States from 2009 to 2015 (in billion U.S. dollars)Spending change on branded and generic medicines in the U.S. 2009-2015
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016U.S. brand and generic prescription drug revenue 2005-2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016Branded vs. generic U.S. drug prescriptions dispensed 2005-2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)Savings through generic drug usage in the U.S. 2008-2017
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*Biggest selling drugs with patent at threat in the U.S. in 2017, by revenue
- Outlook
The most important statistics
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by regionForecast of CAGR global pharmaceutical industry by region 2015-2018
- Forecast of global medicine spending distribution in 2020, by region*Global spending on medicines by regional share forecast 2020
- Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2021
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*Top branded biologic drugs in the U.S. that will go generic by 2028
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)Leading U.S. pharmaceutical products by revenue 2024
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)Healthcare and pharmaceutical industry digital ad spend in the U.S. 2011-2019
- The consumer's view
The most important statistics
- How is your overall impression of the U.S. pharma industry?U.S. adults impression of the U.S. pharma industry
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?U.S. adults that believe physicians are under pressure from pharma to prescribe drugs
- How would you rate the U.S. pharma companies concerning the quality of their drugs?U.S. adults impression of the U.S. pharma drug qualities
- How would you rate the U.S. pharma companies concerning their fairness towards patients?U.S. adults impression of the U.S. pharma companies fairness towards patients
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017U.S. adults who would rate selected pharma features as excellent or good 2017
- Which of these pharma companies do you prefer when buying drugs?Preferred pharma companies by Americans for drug purchase 2017
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*Americans on US pharma quality compared to foreign pharma 2017
Popular Related Keywords
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Availability of new medicines in selected countries 2013
- U.S. insured patients' out-of-pocket health spending 2008-2011
- Changes in prescriptions for older people in the U.S. 2011
- Changes in prescriptions for U.S. young adults
- Global pharmaceutical product launches by therapy area 2004-2013
- Medicine spending share globally in 2007,2017 and 2022, by country group
- Top therapy spending areas in pharmerging markets 2018
- Prescription per capita in the United States by age group 2013
- Medicinal market growth worldwide including rebates 2009-2018
- Medicinal market growth by world region, specialty and traditional 2013-2018
- Reasons for rejected payer retail prescriptions in the U.S. in select classes 2013
- Change in U.S. rate of medicine use by patient age 2013
- Top therapy areas in the U.S. by number of prescriptions 2016
- Total and per capita change in U.S. prescriptions 2004-2013
- Small molecules facing loss of developed market exclusivity 2011-2020
- Medicine and prescriptions: weekly household expenditure in the UK 2017, by type
- Domestic sales value of biological product in Taiwan 2008-2017
- Number of Canadian laboratory medicine specialists 2018, by area
- Reputation of pharmaceutical companies in France 2015
- Domestic demand of surface-active agents Japan 2012-2017
Studies
- Personalized medicine
- Over-the-counter medicine industry in the United Kingdom
- Pharmaceutical industry in Japan
- Public Perspectives on Personalized Medicine (May 2018)
- The Personalized Medicine Report 2017
- Meds Entry Watch 2016
- The Access to Medicine Index 2016
- Roland Berger Focus - Regenerative medicine
- Top pharmaceutical drugs
- Patented Medicine Prices Review Board - Annual Report 2017
- Value of Personalized Medicine (Spring 2015)
- Patented Medicine Prices Review Board - Annual Report 2016
- Complementary Medicines Australia 2017/18 Federal pre-Budget Submission
- Medicines Use and Spending in the U.S. - A Review of 2016 and Outlook to 2021
- Egenvårdsmarknaden 2016
Statistics on the topic
Free statistics
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*
- Number of new molecular entities launched in the U.S. from 2003 to 2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014
- Change in branded and generic medication spending in the United States from 2009 to 2015 (in billion U.S. dollars)
- Forecast of global medicine spending distribution in 2020, by region*
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*
- How is your overall impression of the U.S. pharma industry?
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017
- Which of these pharma companies do you prefer when buying drugs?
- Largest changes in medical prescriptions for older people in the U.S. in 2011 (per 1,000 population)
- Largest changes in medical prescriptions for young adults in the U.S. in 2011* (per 1,000 population)
- Global pharmaceutical product launches between 2004 and 2013, by therapy area*
- Top therapy areas in pharmerging markets in 2018, by spending (in billion U.S. dollars)*
- Distribution of reasons for rejected payer retail prescriptions in the United States in 2013
- Change in rate of medicine use in U.S. in 2013, by patient age*
- Top 20 therapy areas in the United States in 2016, by number of prescriptions (in millions)
- Change in nominal and per capita dispensed prescriptions in United States from 2004 to 2013
- Number of laboratory medicine specialists in Canada as of 2018, by area
Premium Statistics
- Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*
- Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*
- Market share of top 10 national pharmaceutical markets worldwide in 2016*
- Growth of top 10 national pharmaceutical markets worldwide from 2011 to 2016*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- Leading countries in global life sciences mergers and acquisitions in 1st half of 2018
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*
- Johnson & Johnson's total revenue from 2005 to 2017 (in million U.S. dollars)
- Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)
- Total revenue of Merck & Co. from 2006 to 2017 (in million U.S. dollars)
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*
- Top 20 companies based on unbranded generics U.S. market share during 2014-2015*
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by region
- Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?
- How would you rate the U.S. pharma companies concerning the quality of their drugs?
- How would you rate the U.S. pharma companies concerning their fairness towards patients?
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*
- Global new molecular entities availability in selected countries in 2013*
- Insured patients' out-of-pocket costs in the U.S. from 2008 to 2011 (in billion U.S. dollars)
- Global medicine spending distribution in 2007, 2017 and 2022, by country group
- Prescriptions per capita in the U.S. in 2013, by age group*
- Global medicinal market growth including rebates from 2009 to 2018 (in billion U.S. dollars)
- Projected distribution of global medicinal market growth from 2013 to 2018, by region and type of medicine*
- Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020 (in billion U.S. dollars)
- Average weekly household expenditure on medicines, prescriptions and healthcare products in the United Kingdom (UK) in 2017, by type (in GBP)
- Domestic sales value of biological product in Taiwan between 2008 and 2017 (in million New Taiwan dollars)
- Detailed image of pharmaceutical laboratories according to the French in 2015*
- Domestic demand of surface-active agents in Japan from 2012 to 2017 (in 1,000 tons)
Statista Accounts: Access All Statistics. Starting from $588 / Year
Topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account |
Instant Access
Premium Account | ||
|---|---|---|---|
Our servicesClick the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
News
Latest News
New
New Dossier: Food trends in the Netherlands
From organic and sustainable food to ‘free from’ products and alternative diets: this new Statista dossier about food trends in the Netherlands covers all you might want to know about what is hot and happening in the Dutch food market.
New
New Dossier: Direct selling market worldwide
The direct selling market refers to a business model in which products are sold without a 'Brick and Mortar' retail establishment, such as online or person-to-person. This dossier provides key data about this market, with a focus on the United States and the leading companies, such as Amway.
New
New Dossier: E-commerce in Argentina
Argentina is the second largest e-commerce market in Latin America as of 2017. This dossier provides key information about the different aspects of the e-commerce market in Argentina, including the main retailers, customers, mobile commerce, and more.
New
New Dossier: Mobile device usage in Belgium
Recent studies showed that Belgium has the highest prices when it comes to mobile data in Europe, with Proximus, Orange and Telenet as the main actors in this market. This dossier provides information on two of these main players and also features data on mobile commerce, video and apps.
New
New Topic page: Chinese tourism in Europe
China’s travel boom has had a notable impact across the global tourism industry, not least in Europe where China is recognized as a key visitor market. This topic page and accompanying dossier highlights the rising number of Chinese tourists in Europe and the main destinations they are heading to.
New
New Topic Page: Trade across the Irish border
With the UK making plans to leave the EU, it is still uncertain about how this will affect trade across the UK's only land border, the Irish border. This topic highlights the importance of cross border trade and discusses how firms across Ireland are anticipating Brexit to impact their businesses.
New
Global Industry Reports available now!
Statista now offers industry insights from a global perspective for 34 industries. The reports provide crucial information on the trends moving all major industries. Get a bird’s-eye view on your industry, complete with all essential data, KPIs, and exclusive Statista data.
New
New Smart TV Industry Whitepaper
Statista Research and Analysis, in cooperation with Chinese smart TV manufacturer TCL Multimedia and its subsidiary FFalcon Technology, is going to present a new white paper on the global Smart TV industry on September 15th, 2018 during the International Broadcasting Convention (IBC) in Amsterdam.
New
New Dossier: Electric vehicles in Italy
Is Italy speeding up on electric mobility or is the next charging point still too far away? Have a deeper look into the topic with this new dossier. Statista provides an overview on the market situation and customer attitudes around e-mobility in this country so passionate about cars.
New
New Topic Page: Brexit negotiations
With an October deadline looming and an unpopular proposal in hand, time is running out for Theresa May to secure a deal with the European Union. This topic highlights some the main issues standing in the way of a deal and explores how the British public have reacted to the ongoing political drama.
New
New Dossier: eSports in the Benelux region
Revenue might still pale in comparison to other sports, but the recent growth of electronic sports, or eSports, has been immense. This dossier analyzes the popularity of video games and digital games in the Netherlands and the attitude shown towards the trend of online gaming.
New
New topic page: Organic cosmetics in the UK
As consumers become aware of the potentially harmful ingredients used in conventional beauty products, many are seeking green alternatives which pose a lesser risk to the skin and the environment. This topic page provides an overview of natural and organic cosmetic sales and UK consumer attitudes.
New
New Statista Study: European Football Benchmark
Just in time for the start of the new Premier League season, Statista launches the European Football Benchmark: The first football study that compares the 5 big European leagues from a fan's perspective. Find out everything about the Premier League, its clubs, sponsors and fans.
New
New tutorial video on the Global Consumer Survey
The Statista Global Consumer Survey offers a global perspective on consumption and media usage, covering the offline and online world of the consumer. The new tutorial video shows all functionalities and illustrates how you can use the DIY analysis tool effectively.
New
Consumer Electronics Report 2018 out now!
Market reports for the Statista Consumer Market Outlook will now be released roughly every other week starting with the Consumer Electronics Report 2018. The market reports include data as well as qualitative insights into market drivers, consumer behaviour, trends, sales channels and key players.
Updated
In-depth eMobility Report updated & extended
The trend topic eMobility affects many industries and constantly attracts new players. Our updated in-depth report contains all relevant data and insights and includes an excel file with a detailed list of electric cars, trucks, cargo vehicles, buses, and their specifications.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.